Property:Outcome specification
This is a property of type Text.
D
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Percentage of patients who have an improvement on at least one scale of the MYCaW, arm comparison +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Before and after the 4 sessions: Change in values before and after treatment at the respective 4 points in time +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Qualitative responses of the patients analysed by framework analysis +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Overall well-being scores and levels of relaxation.
Before the first and after the last session: main complaints according to own statement +
'''Maximum grade of mucositis'''
according to a modified RTOG/EORTC classification:
Mucosal reaction Score
No change: 0
Mild erythema: 1
Marked erythema: 2
Focal mucositis: 3
Confluent mucositis: 4
Scoring was done weekly by two independent investigators, and a second time during each week by one of these investigators. If the scores of the two investigators differed, the higher score was used for analyses. +
'''Average mucositis'''
Score was calculated from the individual values between week 1 and 6 of radiotherapy. For this, missing values were generated by increasing interpolation between adjacent values, which in particular results in continuation of the previous value if it is similar to the subsequent value.
Grade of mucositis according to a modified RTOG/EORTC classification:
Mucosal reaction Score
No change: 0
Mild erythema: 1
Marked erythema: 2
Focal mucositis: 3
Confluent mucositis: 4
Scoring was done weekly by two independent investigators, and a second time during each week by one of these investigators +
E
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
Change in RPSAS-value +
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
Response rate = at least two fewer chronic radiation-induced proctopathy symptoms
(diarrhea, urge to defecate, rectal pain, tenesmus, rectal bleeding, fecal incontinence) +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
Severity: FLIE
mild = ≤6;
moderate = 7-12;
severe = 13-15
Frequency: Diary entries
All participants recorded daily in a diary (number, consistency of stools, occurrence of symptoms such as nausea, vomiting and gastrointestinal cramps) from day 1 of the 2nd week to the end of the 5th week +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
severity: CTCAE
normal = 0 or 1
mild = 2 or 3
severe = 4
Frequency: Diary entries
All participants recorded daily in a diary (number, consistency of stools, occurrence of symptoms such as nausea, vomiting and gastrointestinal cramps) from day 1 of the 2nd week to the end of the 5th week +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
NI +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
Duration, severity and onset of oropharyngeal mucositis according to the dose of RT +
F
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
Prevalence, severity and duration of nausea in acute (day 1) and delayed phases (day 2-3) +
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
Prevalence and severity of vomiting in acute (day 1) and delayed phases (day 2-3) +
Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? +
EE: excretion fraction; FUR: first-minute uptake ratio; MSP: maximum secretion percentage; MUR: maximum uptake ratio +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Change in NRS value for average pain +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Specification NRS: constipation NRS +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Change in NRS value for the worst pain +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
General intake, appropriate opioid intake for breakthrough pain and total opioid intake per day in morphine equivalents +